At a meeting last week of an FDA advisory committee, vaccine experts suggested that the agency require the pharmaceutical companies to hold larger and longer clinical trials for the younger age groups. A few said FDA should hold off on authorizing vaccination of younger children for up to a year or two.
from Section Page News - Modern Healthcare https://ift.tt/3wzD9PL
No comments:
Post a Comment